Evercore ISI Raises Price Target for Edwards Lifesciences (EW) to $102, Citing Business Transformation

gurufocus.com · 2026-10-23

On October 23, 2026, Evercore ISI updated its price target for Edwards Lifesciences Corp (NYSE: EW) to $102 from $100 and maintained an Outperform rating, highl

TickrTrends take: Edwards Lifesciences operates in the Healthcare sector and currently carries an Undervalued designation from TickrTrends. Evercore ISI's price target elevation to 102 suggests analyst confidence in the company's operational evolution and strategic direction. Valuation-focused readers should monitor whether EW's market price moves toward this target level, as this analyst action could indicate the market has not fully priced in the benefits of the company's business transformation efforts.

Read the full story at gurufocus.com →